Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Rethinking drug efficacy: research aims to improve drug development

    ... build on this work by applying the approach to different therapeutic areas and exploring the implications for drug formulation and ... Postdoctoral Fellow in 2023, are developing a startup with technology that will allow drug developers to test the impact of ... altering the current drug development procedures, the technology has potential to facilitate the creation of entirely novel drug ...

    sommers - 03/11/2024 - 8:54am

  2. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    ... for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark.   The drug is an allosteric ... The FDA then reviews all submitted data. If approved, the therapeutic will be made available for use by the public and be monitored for ... collaboration was facilitated by the   Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...

    sommers - 01/17/2024 - 10:08am

  3. Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment

    ... A cell-penetrating, anti-inflammatory peptide developed by  Jacek Hawiger , Louise B. McGavock Chair and ... The licensing agreement, facilitated by the  Center for Technology Transfer and Commercialization  and the Office of the Vice Provost ...

    sommers - 10/30/2020 - 12:45pm

  4. Tech Connect, Vol. 7, Issue 5: New study shows Play Nicely™ program is an effective positive parenting strategy

    ... Technology Spotlight:  microRNAs Inhibition of Selected ... project is now exploiting an antisense microRNA (anti-miR) therapeutic strategy directed to the inhibition of either one or two target ...

    steelmk - 11/15/2016 - 2:29pm

  5. Early effort to thwart chikungunya infection shows positive results

    ... To protect it, the Moderna team encapsulated it in a lipid nanoparticle using in their proprietary technology. Pre-clinical studies suggested that once injected, cells will take ... study shows for the first time the ability to generate therapeutic levels of a complex protein in humans through systemic ...

    sommers - 09/27/2019 - 9:55am

  6. Tech Connect, Vol. 6, Issue 7: Collaboration seeks to develop new therapies for bone and other diseases

    ... protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic ... Manager of Biotech Licensing in the  Vanderbilt Center for Technology Transfer & Commercialization , facilitated the agreement with La ...

    steelmk - 11/15/2016 - 4:11pm

  7. Tech Connect, Vol. 6, Issue 12: nPhase closes on its first round of funding

    ... Held a call with an agriculture and animal health technology development group to discuss the insect repellent compounds created ... company interested in continuing the development of the peptide therapeutic developed by Fang Yan from the  Department of Pediatric ...

    steelmk - 11/15/2016 - 2:58pm

  8. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... cover specific predictive biomarkers that cover a range of therapeutic classes.   Emanuel Petricoin, Ph.D., Chair of Theralink’s ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm

  9. The yin and yang of cell signaling

    ... Lawrence Marnett , PhD, and colleagues used CRISPR-Cas9 technology to generate stable knock-outs of LYPLA1 and/or LYPLA2 in mouse ... Their work, published this month in the  Journal of Lipid Research , showed that LYPLA1 and LYPLA2 compensated for the loss of ...

    sommers - 02/21/2019 - 9:51am

  10. Oral administration of levocarnitine for treating Sjögren's Syndrome-associated dry eye

    ... have identified levocarnitine as a novel potential therapeutic for treating this condition.   Addressed Need ... provide only temporary relief from symptoms. The proposed technology of oral levocarnitine administration offers a novel approach for ...

    cttc_admin - 02/15/2024 - 1:31pm